Clinical trials
Anemia trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
172 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 5 |
| 2005 | 4 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 6 |
| 2012 | 8 |
| 2013 | 4 |
| 2014 | 12 |
| 2015 | 8 |
| 2016 | 8 |
| 2017 | 15 |
| 2018 | 8 |
| 2019 | 17 |
| 2020 | 17 |
| 2021 | 8 |
| 2022 | 10 |
| 2023 | 11 |
| 2024 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 172 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aga Khan University | 4 |
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | 4 |
| Cornell University | 3 |
| Institute of Hematology & Blood Diseases Hospital, China | 3 |
| OrSense, Ltd. | 3 |
| Peking University | 3 |
| Radboud University Medical Center | 3 |
| Assiut University | 2 |
| Groupe Francophone des Myelodysplasies | 2 |
| Helios Klinik Gotha/Ohrdruf | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia | 172 |
| Anemia, Iron-Deficiency | 16 |
| Renal Insufficiency, Chronic | 11 |
| Iron Deficiencies | 10 |
| Kidney Failure, Chronic | 10 |
| Malaria | 6 |
| Myelodysplastic Syndromes | 6 |
| Neoplasms | 6 |
| Hematologic Diseases | 5 |
| Hemorrhage | 5 |
Trials
Showing 1 to 25 of 172. Each trial links to its page on Pharma Observatory.
72 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.